457 results on '"Bisaga, Adam"'
Search Results
2. A Virtual-First Telehealth Treatment Model for Opioid Use Disorder
3. Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials
4. Rapid Initiation of Injection Naltrexone for Opioid Use Disorder
5. Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial
6. Quetiapine treatment for cannabis use disorder
7. Initiating Long-acting Injectable Naltrexone: Procedure for a Second Attempt After a First Attempt Fails
8. Characteristics of Adolescents with and without a Family History of Substance Use Disorder from a Minority Cohort.
9. Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users
10. Clinical Implications of the Relationship Between Naltrexone Plasma Levels and the Subjective Effects of Heroin in Humans
11. Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis
12. “Because of this rotation, this is what I want to do”: Implementation and evaluation of a telehealth opioid use disorder clinical placement for nurse practitioner students
13. T8 - Association of Baseline Fentanyl Use and Opioid Withdrawal Symptoms During Inpatient Buprenorphine Initiation in a Large Multisite Detoxification Trial
14. M118 - Patient Characteristics of Fentanyl Positive Individuals With Opioid Use Disorder
15. Developing an opioid use disorder treatment cascade: A review of quality measures
16. Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial
17. Urine Drug Screening in a Telehealth Setting for the Treatment of Opioid Use Disorder
18. Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk
19. Telehealth for opioid use disorder: retention as a function of demographics and rurality
20. Prescription psychostimulants for cocaine use disorder: A review from molecular basis to clinical approach
21. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial
22. The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone
23. Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone
24. Evidence-based Treatment for Stimulant Use Disorder: Time to Hit the Community
25. A Virtual-First Telehealth Treatment Model for Opioid Use Disorder
26. Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR?
27. A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence
28. Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential
29. Naltrexone treatment for opioid dependence: Does its effectiveness depend on testing the blockade?
30. Assessment of riboflavin as a tracer substance: Comparison of a qualitative to a quantitative method of riboflavin measurement
31. Clinical Studies Using NMDA Receptor Antagonists in Cocaine and Opioid Dependence
32. Shapes of subcortical structures in adolescents with and without familial history of substance use disorder
33. Continuing Increase in Stimulant Dependence – Time to Implement Medical Treatment
34. A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence
35. Insula Damage and Quitting Smoking [with Response]
36. Benzodiazepines and Other Sedatives and Hypnotics
37. A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period
38. Sex Differences and Hormonal Influences on Response to Mechanical Pressure Pain in Humans
39. White matter integrity and functional connectivity in adolescents with a parental history of substance use disorder
40. Ling et al.ʼs ‘Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder’
41. Baseline characteristics of patients predicting suitability for rapid naltrexone induction
42. Google Trends Data: A Potential New Tool for Monitoring the Opioid Crisis
43. Pilot randomized placebo‐controlled clinical trial of high‐dose gabapentin for alcohol use disorder
44. Memantine reduces consumption of highly palatable food in a rat model of binge eating
45. Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence
46. Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice
47. Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder
48. Evaluation of potential sex differences in the subjective and analgesic effects of morphine in normal, healthy volunteers
49. Drug treatment of SARS-Cov2: Potential effects in patients with substance use disorders (SUD)
50. A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.